These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28282891)

  • 1. Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy.
    Key J; Park K
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
    Lee SJ; Min HS; Ku SH; Son S; Kwon IC; Kim SH; Kim K
    Nanomedicine (Lond); 2014 Aug; 9(11):1697-713. PubMed ID: 25321170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan nanopolymers: An overview of drug delivery against cancer.
    Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
    Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current advance of nanotechnology in diagnosis and treatment for malignant tumors.
    Wang B; Hu S; Teng Y; Chen J; Wang H; Xu Y; Wang K; Xu J; Cheng Y; Gao X
    Signal Transduct Target Ther; 2024 Aug; 9(1):200. PubMed ID: 39128942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.
    Na JH; Koo H; Lee S; Min KH; Park K; Yoo H; Lee SH; Park JH; Kwon IC; Jeong SY; Kim K
    Biomaterials; 2011 Aug; 32(22):5252-61. PubMed ID: 21513975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles.
    Zhu HZ; Hou J; Guo Y; Liu X; Jiang FL; Chen GP; Pang XF; Sun JG; Chen ZT
    Drug Deliv; 2018 Nov; 25(1):1974-1983. PubMed ID: 30621480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How nanomedicine can be used in the treatment of tumors: an interview with Dr Gang Zheng.
    Zheng G; Overchuk M
    Nanomedicine (Lond); 2018 Nov; 13(22):2817-2820. PubMed ID: 30421644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanoparticles for multimodal imaging and theragnosis.
    Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC
    Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Cancer Imaging with Polymeric Nanoassemblies: From Tumor Detection to Theranostics.
    Mi P; Wang F; Nishiyama N; Cabral H
    Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27739631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-based nanoparticles for tumor-targeted drug delivery.
    Prabaharan M
    Int J Biol Macromol; 2015 Jan; 72():1313-22. PubMed ID: 25450550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique roles of nanotechnology in medicine and cancer.
    Alam F; Naim M; Aziz M; Yadav N
    Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine and Early Cancer Diagnosis: Molecular Imaging using Fluorescence Nanoparticles.
    Jin KT; Yao JY; Ying XJ; Lin Y; Chen YF
    Curr Top Med Chem; 2020; 20(30):2737-2761. PubMed ID: 32962614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
    Tian B; Hua S; Liu J
    Carbohydr Polym; 2023 Sep; 315():120972. PubMed ID: 37230614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal cancer treatment: real time monitoring, optimization, and synergistic effects.
    Myhr G
    Technol Cancer Res Treat; 2008 Oct; 7(5):409-14. PubMed ID: 18783293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for cancer therapy using magnetic forces.
    Tietze R; Lyer S; Dürr S; Alexiou C
    Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.